Diagnostic Value of Plasma Annexin A2 in Early-Stage High-Grade Serous Ovarian Cancer
Ovarian cancer (OC) is commonly diagnosed at advanced stage when prognosis is poor. Consequently, there is an urgent clinical need to identify novel biomarkers for early detection to improve survival. We examined the diagnostic value of the calcium phospholipid binding protein annexin A2 (ANXA2), wh...
Main Authors: | Noor A. Lokman, Carmela Ricciardelli, Andrew N. Stephens, Thomas W. Jobling, Peter Hoffmann, Martin K. Oehler |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/1/69 |
Similar Items
-
Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer
by: Noor A. Lokman, et al.
Published: (2019-01-01) -
CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer—A Multicenter Analysis
by: Christoph Wohlmuth, et al.
Published: (2022-04-01) -
Identification of Malignant Cell Populations Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer Using Single-Cell RNA Sequencing
by: Naoki Sumitani, et al.
Published: (2022-07-01) -
Deciphering the Molecular Nature of Ovarian Cancer Biomarker CA125
by: Peter Hoffmann, et al.
Published: (2012-08-01) -
Clinical Presentation of Pelvic Tuberculosis Imitating Ovarian Malignancy
by: Yun-Ju Huang, et al.
Published: (2004-03-01)